However, we detected somatic mutations associated with telomerase activation or ALT in only a subset of gliomas, and their genetic signatures were not perfectly correlated with TMM status; thus, we could not accurately predict TMM group membership on the basis of these mutations. The gene discussed is GPT; the disease is glioma.